5,686 results on '"Solid tumors"'
Search Results
2. Screening Study for Participants With Malignant Tumors
3. A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-301)
4. Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
5. Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
6. QTX3034 in Patients With KRAS G12D Mutation
7. A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body
8. Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
9. Ceramide NanoLiposome in Patients With Advanced Solid Tumors
10. Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
11. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors
12. Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
13. Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
14. A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors (ARC-20)
15. A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
16. Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
17. Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
18. Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
19. Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
20. An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
21. Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
22. A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors
23. The Effects of Ginseng on Cancer-Related Fatigue
24. Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
25. Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
26. A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
27. Avelumab Program Rollover Study
28. A Study to Test Different Doses of BI 1831169 Alone and in Combination With Ezabenlimab in People With Different Types of Advanced Cancer (Solid Tumors)
29. Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
30. Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
31. A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H) (IMperator)
32. A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
33. Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
34. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
35. Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
36. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)
37. Phase I Comparative Bioavailability Study
38. A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor
39. Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors
40. Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
41. NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
42. TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
43. GEN1046 Safety Trial in Patients With Malignant Solid Tumors
44. Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors (KEYNOTE-603)
45. Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
46. Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
47. MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
48. A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
49. Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
50. A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.